Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Am J Ophthalmol. 2015 Nov 6;162:140–149.e1. doi: 10.1016/j.ajo.2015.10.025

Table 2.

Percent visualization of the features of the posterior vitreous and vitreoretinal interface in healthy non-diabetic control eyes, diabetic eyes without retinopathy and diabetic eyes with different stages of retinopathy using vitreous enhanced three-dimensional swept-source optical coherence tomography imaging. n represents the number of eyes. p values represent the results of one-way analysis of variance. Significant p values are in bold.

FEATURE OBSERVED % of Healthy Non-Diabetic Eyes with Feature (n=22) % of Diabetic Eyes without Retinopathy with Feature (n=20) % of Eyes with NPDR with Feature (n=21) % of Eyes with PDR with Feature (n=20) % of Eyes with DME with Feature (n=27) p value

1. Bursa Premacularis 17/22, 77% 15/20, 75% 14/21, 67% 13/20, 65% 17/27, 63% 0.22
2. Area of Martegiani 16/22, 73% 14/20, 70% 13/21, 62% 13/20, 65% 15/27, 56% 0.09
3. Posterior vitreous cortex (hyaloid) detachment 18/22, 82% 17/20, 85% 18/21, 86% 17/20, 85% 23/27, 85% 0.18
4. Thick posterior hyaloid NA 0/20, 0% 4/21, 19% 11/20, 55% 11/27, 41% p=0.0001
5. Vitreoschisis 6/22, 27% 9/20, 45% 10/21, 48% 13/20, 65% 17/27, 63% p=0.007
6. Adhesions (pegs) between the detached posterior hyaloid and inner retinal surface 0/20, 0% 0/20, 0% 1/21, 4% 11/20, 55% 11/27, 41% p=0.0001
7. Vitreous clumping 11/22, 50% 11/20, 55% 13/21, 62% 13/20, 65% 18/27, 67% 0.10

Abbreviations: NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; DME, diabetic macular edema; NA, not applicable